Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
Front view, side view, and back view in same lighting wearing minimal clothing
doi:10.1017/S0033291716002932 Adeoye O, Olawumi J, Opeyemi A, Christiania O
Tirzepatida por vial: concentracin final y nmero de rplicas La etiqueta expresa masa total, no concentracin
The Avli treatment is a three-step process that targets the root cause of cellulite
Switching medications isnt a failure